{{Rsnum
|rsid=9822268
|Gene=APEH
|Chromosome=3
|position=49682296
|Orientation=plus
|GMAF=0.2351
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=APEH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 42.5 | 53.1
| HCB | 0.0 | 10.2 | 89.8
| JPT | 0.0 | 14.3 | 85.7
| YRI | 9.5 | 32.0 | 58.5
| ASW | 10.5 | 49.1 | 40.4
| CHB | 0.0 | 10.2 | 89.8
| CHD | 1.8 | 10.1 | 88.1
| GIH | 5.0 | 35.0 | 60.0
| LWK | 14.8 | 41.7 | 43.5
| MEX | 5.4 | 37.5 | 57.1
| MKK | 12.2 | 39.7 | 48.1
| TSI | 8.0 | 51.0 | 41.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21297633
|Trait=None
|Title=Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
|RiskAllele=A
|Pval=2E-17
|OR=1.2100
|ORtxt=[1.16-1.26]
|OA=1
}}

{{PMID|17804789|OA=1
}} Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}